Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities)
The "Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities)" is 1 of 18 course in the Introduction to Immuno-Safety Science module.
This course is led by Dr. Rashade Haynes at Bristol Myers Squibb PhD
Learning Objectives
1. Types of innate immune cells |
2. Broad categories of innate immune cell therapies and in what therapeutic areas they're most commonly used |
3. Types of toxicities with these therapies |
4. Future directions of these therapies? |